seed
Stage
2
Investors
About
Maracells develops precision oncology solutions by using cell-based assays to predict patient response to cancer treatments, aiming to personalize cancer therapy.
Explore Maracells's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.